Gain detailed insights into the trading activity of Congress members for ZTO Express (Cayman) on our government trades page. Stay updated on how elected officials are investing in ZTO.

ZTO Express (Cayman) - Government Trades

ZTO Express (Cayman)

ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 22.1% in 2022. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 77% voting rights as of June 30, 2023. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 11.7% interest.

Temu,App,Seen,On,The,Ipad,Screen.,Temu,Shop,App

Large Cap

News

Movers

Trading Ideas

BABA

INCY

INTU

Citigourp Global Markets 2% Protected Notes Linked To The Djia

ULTA

Large-cap stocks had a rough week, including Target, PDD Holdings, ZTO Express, Tenet Healthcare, Ulta Beauty, Intuit, Nokia, Alibaba, Santander, and Incyte.

Target, Alibaba And Temu Parent PDD Are Among Top 10 Large-Cap Losers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?

JD.com, Inc.

Emerging Markets

BEKE

BGNE

FANG

FUTU

Best performing large-cap stocks in the past week were mostly USA listed Chinese stocks due to additional stimulus measures to boost China&#39;s economy.

US Listed Chinese Stocks Dominate Another Week - Li Auto, JD.com Among Top 10 Large Cap Gainers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?

nyse shutter

Earnings

Equities

Futures

Previews

Economics

Federal Reserve

Pre-Market Outlook

Markets

$BTC

BBAI

KEYS

NDSN

SNOW

SNPS

URBN

WOLF

U.S. stocks could claw back their losses, although nervousness is palpable as traders play the waiting game ahead of Federal Reserve Chair Jerome Powell’s Jackson Hole address on Friday.

Nasdaq, S&amp;P 500 Futures Edge Up As Traders Look Ahead To FOMC Minutes: Strategist Flags 3 Trends That Could Help Stocks Withstand Volatility

Stocks.Watch_.Shutterstock

AMGN

COIN

COTY

INTC

MSTR

PANW

VIPS

The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the recent gains could keep traders wary of a potential pullback.

US Stocks May Take A Breather After S&amp;P 500&#39;s Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks

movers image

Intraday Update

New Oriental Education & Technology Group

GSX Techedu Inc. American Depositary Shares

GOTU

ISPR

TWST

Sotera Health Posts Upbeat Results, Joins Thoughtworks, Sonic Automotive And Other Big Stocks Moving Higher On Monday

ADTH

ASTS

AWIN

BMTX

BRSH

BSFC

CRBG

CRKN

DADA

EXTR

EYEN

FFIE

FLNT

GAMB

GOOS

GWAV

KULR

LSDI

LSPD

MGNI

NICE

OMER

PEGY

REKR

RELI

SBOW

SDOT

SINT

SPIR

TIRX

TRUP

TSRI

WOOF

Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

walmart-store-exterior-at-night.site_

ARVN

BOOT

HUYA

Walmart Posts Upbeat Earnings, Joins Canada Goose, Lightspeed Commerce And Other Big Stocks Moving Higher On Thursday

Santa,Clara,,Ca, - ,Usa,-,March,26,,2019:,Cisco

AGRI

CSCO

IREN

WAVD

Why Cisco Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Wall Street trader

AMAT

BIDU

TTWO

Stocks may take a breather after Wednesday’s record run, fueled by a mild consumer price inflation report, with index futures holding relatively steady in early trading.

Wall Street Eyes Breather After Record Run As Walmart Earnings, Fed Speakers In Focus: Analyst Banks Hopes On Nvidia Print, H2 Rate-Cut

stock charts 3

MNDY

U.S. stock futures were flat Wednesday morning as investors awaited a crucial report on consumer prices.

Wall Street Futures Pause As April Inflation Worries Eclipse Meme Stock Mania 2.0: Why This Analyst Bets May Will Be &#39;Strong Month&#39;

ZTO Express (Cayman) Inc. American Depositary Shares, each representing one Class A ordinary share.

ZTO Express (Cayman) Inc

ZTO EXPRESS (CAYMAN) A by ZTO Express (Cayman) Inc.

Toshi (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TOSHI</a>), a meme coin named after Coinbase co-founder Brian Armstrong, has outperformed meme coin heavyweights like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) over the past week, seeing stellar gains after being <a href="https://www.benzinga.com/quote/COIN">listed on Coinbase</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Toshi (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TOSHI</a>)</td>
<td>&nbsp;$0.00117</td>
<td>$477.8 million</td>
<td>-31.7%&nbsp;</td>
<td>&nbsp;+224.1%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.319&nbsp;</td>
<td>$47 billion</td>
<td>-10%&nbsp;</td>
<td>-12.3%&nbsp;</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001819</td>
<td>$10.7 billion</td>
<td>-8.8%&nbsp;</td>
<td>-11.7%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader BasedTricky emphasized Toshi's strong performance despite market dips, pointing to its impressive $1 billion 24-hour trading volume. 
He <a href="https://x.com/BasedTricky/status/1883873858815463918">predicts</a> that Toshi, dubbed the &#8220;Face of Coinbase,&#8221; could experience a strong rebound as market conditions stabilize.
Another crypto trader, Pennski Hardaway, believes Toshi could redefine the meme coin landscape, especially within Ethereum Virtual Machine (EVM) chains, if it crosses the $1 billion market cap. 
He <a href="https://x.com/0x_Imperius/status/1882588299010908500">sees</a> Toshi as a transformative force that could reignite innovation and enthusiasm in the space, while strengthening Coinbase's position in the crypto industry.
Statistics: Crypto trader rb3k <a href="https://x.com/rbthreek/status/1883333311952777514">noted</a> that the meme coin Toshi occupied the top spot in volume trading on Jan. 26, even outperforming Bitcoin in terms of trading volume.
Over the past seven days, Toshi has accumulated 220% gains leaving behind meme coin leaders like Dogecoin, Shiba Inu and Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>).
Community News: On Jan. 23, Coinbase officially announced Toshi's listing, propelling the token to an all-time high of $0.002273.
However, after a weekend rally, the coin faced a 32% decline in a single day, highlighting its volatility amid broader market uncertainty.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43105356/meme-coin-supercycle-dogecoin-trump-bonk-futures-etf-applications-filed">Meme Coin Supercycle? Dogecoin, Trump, Bonk Futures ETF Applications Filed</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

$TOSHI

Coinbase's Toshi Cat Coin Leaps Past Dogecoin, Shiba Inu With 200% Surge In One Week

BofA Securities analyst downgraded the shares of Bloomin&#8217; Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) from Neutral to Underperform and <a target="_blank" href="https://www.benzinga.com/quote/BLMN/analyst-ratings" rel="noreferrer noopener">lowered the price forecast from $18.00 to $13.00.</a>
Over the last decade, Bloomin&#8217;s transaction growth has averaged a decline of approximately 2% per year across its brands, with its largest brand, Outback, seeing a -1.1% compound annual growth rate (CAGR) in traffic, said the analyst.
Outback US accounted for about 51% of Bloomin&#8217;s (BLMN) revenue in FY24, and following the Brazil licensing, this is expected to rise to around 53%.
Also Read: <a href="https://www.benzinga.com//node/43241652">Starbucks Q1 Earnings Preview: Data Shows Visits Down, Will Company Continue Streak Of Missing Revenue Estimates?</a>
While the casual dining sector generally experiences slow growth, Bloomin&#8217;s challenges have allowed competitors to gain a larger market share. The new management&#8217;s primary focus is on reversing the decline in traffic, noted the analyst.
Although BLMN&#8217;s volumes have consistently decreased, its margins have remained unexpectedly strong. Domestic same-store transaction counts across the BLMN system are roughly 10% lower than in 2019, but restaurant margins have only dropped by 70 basis points.
With flow-through margins around 40% on additional transactions, the analyst would have anticipated a margin decline closer to 260 basis points compared to 2019.
The fact that their pricing has been on par with or higher than direct competitors such as Texas Roadhouse Inc in the steak category, supports this perspective.
While turnarounds in casual dining are uncommon, they are not unattainable, as demonstrated by Chili&#8217;s. However, its parent company, Brinker International Inc made substantial investments in labor to enhance service and marketing efforts to attract customers.
To balance this, Brinker implemented significant price hikes. In contrast, the analyst notes an important difference between Chili&#8217;s and Bloomin&#8217; is that Chili&#8217;s had historically underpriced its competitors.
Bloomin&#8217;s brands, on the other hand, have maintained competitive pricing and lack the scale advantages within their segments to outspend rivals on marketing or value without compromising margins.
Although BLMN is currently priced below its historical average, the analyst anticipates that both revenue and earnings projections will continue to face pressure in the near future.
Price Action: BLMN shares are trading lower by 0.36% at $12.27 at the last check Monday.
Photo via Shutterstock.

Analyst Color

Downgrades

Price Target

Analyst Ratings

General

BLMN

TXRH

Bloomin' Brands Faces Near-Term Pressure, Analyst Highlights Peer Brinker's Turnaround Roadmap

Ahead of their earnings release, BofA Securities analyst Lawson Winder upgraded Kinross Gold Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>) and downgraded Barrick Gold Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>).
Talking about market, the analyst says that Gold opened at $2,706/oz last week, rising to $2,746/oz on January 21, 2025, as the U.S. Dollar weakened.
It closed the week at $2,771/oz, up 2.5%, on President Trump&#8217;s remarks on a less aggressive tariff approach to China.
KGC: The analyst double-upgraded Kinross from Underperform to Buy and raised the price <a target="_blank" href="https://www.benzinga.com/quote/kgc/analyst-ratings" rel="noreferrer noopener">forecast from $9.25 to $12.75</a>.
The analyst notes several concerns surrounding Kinross, such as shorter mine life, maintaining 2 million gold equivalent ounces (GEOs) of annual production, and unit costs, are being addressed.
Consequently, the analyst raised the 2026 GEO production forecast from 1.8 million to 2 million GEO and increased earnings per share (EPS) estimates from $0.64 to $0.78 for 2026.
Despite market concerns about potential corporate acquisitions, Kinross remains disciplined in this regard, adds the analyst.
Additionally, Winder sees potential for Kinross to boost capital returns in 2025 through a share buyback. Overall, the analyst says that the company is well-positioned for fourth-quarter results with potential catalysts in 2025.
GOLD: The analyst downgraded the stock from Buy to Neutral and cut the <a target="_blank" href="https://www.benzinga.com/quote/gold/analyst-ratings" rel="noreferrer noopener">price forecast from $21 to $18</a>.
The analyst writes that as approaching fourth-quarter results, risks are rising, particularly regarding the shutdown of the Loulo-Gounkoto mine in Mali, and the struggling ramp-up of the Pueblo Viejo mine in the Dominican Republic.
In their 2025 model, Winder removed any production from the Loulo-Gounkoto mine due to its suspension amid a tax dispute with the Malian military government.
The analyst says that he sees two possible outcomes: the first, a less favorable tax and royalty agreement allowing continued operation; the second, a complete loss of operations if the government seizes control.
The analyst assumes the mine to restart in late 2025, ramping up to full production in 2026, but under less favorable terms for Barrick Gold.
Consequently, the analyst lowered 2025 estimates for EPS to $1.55 from $1.91 and 2026 EPS to $1.81 from $1.92.
Both Kinross and Barrick Gold will release their fourth-quarter results on <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">Wednesday, February 12, 2025</a>.
Price Action: KGC shares are down 0.89% at $10.60, while GOLD shares are down 1.18% at $15.94 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/01/43093586/barrick-looks-into-portfolio-optimization-sees-pakistan-as-the-new-frontier" target="_blank" rel="noreferrer noopener">Barrick Looks Into Portfolio Optimization, Sees Pakistan As &#8216;The New Frontier&#8217;</a></li>
</ul>
Image via Shutterstock.

Upgrades

GOLD

Kinross Gold's Production Outlook Improves, Analyst Double Upgrades Stock

On Monday, Allakos Inc (NASDAQ:&nbsp;ALLK) revealed topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41280699/allakos-announces-phase-1-trial-results-of-subcutaneous-ak006-in-healthy-volunteers" rel="noreferrer noopener">(CSU), a skin disorder</a>.
&#8220;While AK006 was well tolerated, we are disappointed that the preclinical inhibitory effects observed did not translate to clinical benefit in patients with CSU. As a result, the company has decided to discontinue further clinical development of AK006,&#8221; said Chin Lee, Chief Medical Officer of Allakos.
In the CSU cohort, 34 adult patients refractory to antihistamines with or without prior exposure to omalizumab were enrolled and randomized 2:1 to receive 720 mg of intravenous AK006 (n=23) or placebo (n=11) once every four weeks (Q4W).
AK006 was well-tolerated with a favorable safety profile. There were no serious adverse events (SAEs) in subjects on AK006.
The company plans to discontinue AK006-related activities across clinical, manufacturing, research, and administrative functions and reduce its workforce by approximately 75%.
The company plans to retain approximately 15 employees to explore strategic alternatives, maintain compliance with regulatory and financial reporting requirements, and wind down the phase 1 clinical trial.
In October, &nbsp;Allakos released results from the Phase 1 study of subcutaneous AK006 in healthy volunteers. Subcutaneously administered AK006 showed approximately 77% bioavailability and prolonged receptor occupancy on mast cells and was well-tolerated with a <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41280699/allakos-announces-phase-1-trial-results-of-subcutaneous-ak006-in-healthy-volunteers" rel="noreferrer noopener">favorable safety profile</a>.
Allakos ended the fourth quarter of 2024 with approximately $81 million in cash, cash equivalents, and investments. The company estimates that cash used in restructuring activities to close out AK006 development, including severance and contractual payments to vendors, will be approximately $34 million to $38 million.
The company also estimates that most of these restructuring costs will be paid over the first and second quarters of 2025.
Allakos estimates that as of June 30, 2025, it will have cash, cash equivalents, and investments of approximately $35 million to $40 million.
Price Action: ALLK stock is down 78.5% at $0.26 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43237896/vci-global-expands-ai-infrastructure-with-25m-investment" target="_blank" rel="noreferrer noopener">VCI Global Expands AI Infrastructure With $25M Investment</a></li>
</ul>

Biotech

Health Care

ALLK

Why Is Allakos Stock Plunging On Monday?

Across the recent three months, 7 analysts have shared their insights on Bloomin Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $14.43, a high estimate of $19.00, and a low estimate of $13.00. Observing a downward trend, the current average is 22.71% lower than the prior average price target of $18.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004457_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Bloomin Brands by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Justin Post</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$13.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Sell</td>
<td>$13.00</td>
<td>-</td>
</tr>
<tr>
<td>John Ivankoe</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$14.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Brian Mullan</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Bloomin Brands. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Bloomin Brands compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Bloomin Brands's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/BLMN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bloomin Brands analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Bloomin Brands</h2>
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.
<h3>Bloomin Brands's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Bloomin Brands faced challenges, resulting in a decline of approximately -3.8% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Bloomin Brands's net margin excels beyond industry benchmarks, reaching 0.67%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Bloomin Brands's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.61%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Bloomin Brands's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.2%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 9.93, Bloomin Brands adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Bloomin Brands Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

Throughout the last three months, 4 analysts have evaluated Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $11.38, with a high estimate of $13.00 and a low estimate of $9.50. Marking an increase of 13.8%, the current average surpasses the previous average price target of $10.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004450_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Nexxen International among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Miller</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Matthew Swanson</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$12.00</td>
<td>$9.50</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$9.50</td>
<td>$8.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Nexxen International. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Nexxen International compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Nexxen International's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Nexxen International's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/NEXN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Nexxen International analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Nexxen International</h2>
Nexxen International Ltd empowers advertisers, agencies, publishers, and broadcasters to utilize video and connected TV. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with advanced and exclusive data at its core.
<h3>A Deep Dive into Nexxen International's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Nexxen International displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 1.81%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: Nexxen International's net margin is impressive, surpassing industry averages. With a net margin of 16.12%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Nexxen International's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.78%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.81%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.07.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NEXN

4 Analysts Assess Nexxen International: What You Need To Know

Ratings for Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $67.0, a high estimate of $69.00, and a low estimate of $65.00. This current average has decreased by 0.74% from the previous average price target of $67.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004441_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Ventas by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$69.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>David Rodgers</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$65.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>David Rodgers</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$66.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Vikram Malhorta</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$68.00</td>
<td>$71.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Ventas. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Ventas compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Ventas's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Ventas's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VTR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ventas analyst ratings.</a>
<h2>All You Need to Know About Ventas</h2>
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
<h3>Financial Insights: Ventas</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Ventas displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 7.52%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Ventas's net margin excels beyond industry benchmarks, reaching 1.56%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ventas's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.2%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Ventas's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.08% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Ventas's debt-to-equity ratio is below the industry average at 1.42, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 4 Analysts Discuss Ventas Stock

Across the recent three months, 5 analysts have shared their insights on CenterPoint Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for CenterPoint Energy, revealing an average target of $33.5, a high estimate of $37.00, and a low estimate of $30.00. Surpassing the previous average price target of $30.50, the current average has increased by 9.84%.
<img src="https://www.benzinga.com/files/images/story/2025/1738004430_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of CenterPoint Energy among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$30.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Paul Fremont</td>
<td>Ladenburg Thalmann</td>
<td>Announces</td>
<td>Buy</td>
<td>$34.50</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Weisel</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$35.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>William Appicelli</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>David Arcaro</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$31.00</td>
<td>$32.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CenterPoint Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of CenterPoint Energy compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for CenterPoint Energy's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of CenterPoint Energy's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CNP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CenterPoint Energy analyst ratings.</a>
<h2>Unveiling the Story Behind CenterPoint Energy</h2>
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio. The company has natural gas distribution systems serving approximately 4 million customers.
<h3>CenterPoint Energy: A Financial Overview</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, CenterPoint Energy faced challenges, resulting in a decline of approximately -0.22% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Utilities sector.
Net Margin: CenterPoint Energy's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 10.4%, the company may face hurdles in effective cost management.
Return on Equity (ROE): CenterPoint Energy's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.85%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): CenterPoint Energy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.46%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.89.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 5 Analyst Projections For CenterPoint Energy

Rambus's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NYSE">RMBS</a>) short percent of float has fallen 11.91% since its last report. The company recently reported that it has 2.81 million shares sold short, which is 3.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.79 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Rambus Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738004423_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Rambus has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Rambus's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Rambus's peer group average for short interest as a percentage of float is 9.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

RMBS

(RMBS) - Analyzing Rambus's Short Interest

Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $94.0, along with a high estimate of $100.00 and a low estimate of $85.00. A 1.31% drop is evident in the current average compared to the previous average price target of $95.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004422_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Consolidated Edison. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$92.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Andrew Weisel</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$100.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>David Arcaro</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$85.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$99.00</td>
<td>$104.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Consolidated Edison. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Consolidated Edison compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Consolidated Edison's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ED/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Consolidated Edison analyst ratings.</a>
<h2>Get to Know Consolidated Edison Better</h2>
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange &amp; Rockland, or O&amp;R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities generate nearly all of Con Ed's earnings following the sale of its clean energy business to RWE in early 2023.
<h3>Consolidated Edison's Financial Performance</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Consolidated Edison displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 5.68%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Utilities sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 14.37%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Consolidated Edison's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.71% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.86%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.2.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Assess Consolidated Edison: What You Need To Know

Primerica's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>) short percent of float has fallen 6.47% since its last report. The company recently reported that it has 335 thousand shares sold short, which is 1.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.52 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Primerica Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738004418_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Primerica has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Primerica's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Primerica's peer group average for short interest as a percentage of float is 2.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Primerica?

Snow Lake Resources's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NYSE">LITM</a>) short percent of float has risen 4.56% since its last report. The company recently reported that it has 2.24 million shares sold short, which is 3.21% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Snow Lake Resources Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738004412_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Snow Lake Resources has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Snow Lake Resources's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Snow Lake Resources's peer group average for short interest as a percentage of float is 4.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

LITM

How Is The Market Feeling About Snow Lake Resources?

Across the recent three months, 21 analysts have shared their insights on Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">10</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.52, a high estimate of $33.00, and a low estimate of $7.00. Witnessing a positive shift, the current average has risen by 50.0% from the previous average price target of $15.68.
<img src="https://www.benzinga.com/files/images/story/2025/1738004412_0_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Bloom Energy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kashy Harrison</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Mark Strouse</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jordan Levy</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$22.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Gregory Lewis</td>
<td>BTIG</td>
<td>Raises</td>
<td>Buy</td>
<td>$30.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$32.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Chip Moore</td>
<td>Roth MKM</td>
<td>Announces</td>
<td>Neutral</td>
<td>$25.00</td>
<td>-</td>
</tr>
<tr>
<td>Julien Dumoulin-Smith</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$20.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$33.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$33.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Lloyd Byrne</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$22.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Kashy Harrison</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Samantha Hoh</td>
<td>HSBC</td>
<td>Announces</td>
<td>Hold</td>
<td>$24.50</td>
<td>-</td>
</tr>
<tr>
<td>Chris Dendrinos</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$28.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Stephen Byrd</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$28.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$20.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Gregory Lewis</td>
<td>BTIG</td>
<td>Raises</td>
<td>Buy</td>
<td>$20.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Kashy Harrison</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Ameet Thakkar</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$19.50</td>
<td>$12.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$16.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$15.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Julien Dumoulin-Smith</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$7.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bloom Energy. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Bloom Energy compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Bloom Energy's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Bloom Energy's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/BE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bloom Energy analyst ratings.</a>
<h2>Unveiling the Story Behind Bloom Energy</h2>
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.
<h3>Bloom Energy's Economic Impact: An Analysis</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Bloom Energy's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -17.46%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Bloom Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -4.45%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -3.44%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Bloom Energy's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.57%, the company showcases efficient use of assets and strong financial health.
Debt Management: Bloom Energy's debt-to-equity ratio surpasses industry norms, standing at 3.93. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Bloom Energy: Insights From 21 Financial Analysts

Goldman Sachs analyst Kash Rangan reiterated a <a target="_blank" href="https://www.benzinga.com/quote/NOW/analyst-ratings" rel="noreferrer noopener">Buy rating</a> on the shares of ServiceNow Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a price forecast of $1,200.
The analyst continues to view the company as a top-tier software leader with sustainable 20% growth potential, supported by a Rule of 50+ profile, as noted in the 2025 outlook.
The analyst expects the company to report Subscription Revenue growth of at least +21.7% in USD/CC, matching consensus, and cRPO growth of +21.5% in USD/CC, versus the consensus estimate of 21.4%.
Also Read: <a href="https://www.benzinga.com//node/43243584">DeepSeek R1 Vs. OpenAI: What Consumers Need To Know About AI&#8217;s Latest Challenger</a>
The stock has risen by 24% since the release of the third-quarter FY24 earnings, outperforming the NASDAQ&#8217;s 9% gain, reflecting investor optimism driven by consistent beat-and-raise results, increasing Gen-AI revenue, and strong go-to-market execution.
Notable metrics include 96 deals worth over $1 million (up 16% YoY) and 6 deals surpassing $10 million, compared to 4 in the second quarter, said the analyst.
According to the analyst, further growth will be supported by cRPO growth and accelerating RPO growth, creating a strong foundation for sustained expansion, AI contributing an additional 2 percentage points of growth in FY24, with further momentum expected as AI agents are introduced and investors respond positively to AI contributions, and solid execution across multiple products, with 18 of the top 20 deals including 7+ products, supporting a diversified growth trajectory.
Despite the recent strength of the dollar, the analyst estimates only a 20 basis points FX benefit to fourth-quarter cRPO and revenue, compared to the 120 basis points benefit initially forecasted, and a potential 110 basis points/~$120 million FX impact on FY25 growth.
In the analyst&#8217;s opinion, ServiceNow has the potential to be a resilient business, even during an economic downturn. The company offers a distinct mix of IT service management and operations, which together make up approximately 70-75% of its revenue.
This core offering can be considered defensive, especially as IT departments become more influential amidst tighter budgets.
The remaining portion of ServiceNow&#8217;s portfolio, focused on employee, customer, and creator workflows, is more aggressive in its growth strategy, positioning the company to capture additional market share.
Despite potential macroeconomic challenges in the short term, the company&#8217;s long-term growth outlook remains strong, with a potential to reach $35 billion in revenue and achieve margins above 40%, noted the analyst.
Price Action: NOW shares are trading higher by 0.94% at $1,135.55 at the last check Monday.
Image: Shutterstock.

Reiteration

Tech

ServiceNow Benefits From Material AI Contribution, Analyst Predicts Solid Q4 Results

U.S. stocks traded mixed toward the end of trading, with the S&amp;P 500 falling over 100 points on Monday.
The Dow traded up 0.22% to 44,521.81 while the NASDAQ fell 3.29% to 19,297.13. The S&amp;P 500 also fell, dropping, 1.84% to 5,988.74.
Check This Out: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43225208/abbott-to-rally-over-26-here-are-10-top-analyst-forecasts-for-monday">Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday</a>
Leading and Lagging Sectors Health care shares surged by 2% on Monday.
In trading on Monday, information technology shares fell by 5.5%.
Top Headline
Dada Nexus Limited  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) received a preliminary, non-binding proposal from JD.com, Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) to acquire all shares, including ADSs, at $2.00 per ADS ($0.50 per Ordinary Share) in cash.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Aurora Mobile Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) shares shot up 130% to $13.30 after the company revealed its GPTBots.ai platform has integrated the DeepSeek R1 large language model.</li>
<li>Shares of Akero Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKRO#NASDAQ">AKRO</a>)got a boost, surging 102% to $52.87 after the company reported preliminary Week 96 results from its SYMMETRY Phase 2B study of Efruxifermin.</li>
<li>Dada Nexus Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) shares were also up, gaining 27% to $1.79 after the company received a preliminary, non-binding proposal from JD.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) to acquire all shares, including ADSs, at $2.00 per ADS ($0.50 per Ordinary Share) in cash.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Allakos Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLK#NASDAQ">ALLK</a>) shares dropped 79% to $0.2524 after the company announced it will discontinue further development of AK006, reduce its workforce by 75%, and explore strategic alternatives.</li>
<li>Shares of Veru Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERU#NASDAQ">VERU</a>) were down 49% to $0.6177 after the company reported results from Phase 2b trial of Enobosarm for muscle preservation in weight loss patients.</li>
<li>PMGC Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELAB#NASDAQ">ELAB</a>) was down, falling 34% to $2.06. PMGC Holdings announced $1.9 million in gross proceeds from warrant inducement with institutional investors.</li>
</ul>
Commodities In commodity news, oil traded down 2.7% to $72.66 while gold traded down 1.6% at $2,733.40.
Silver traded down 3.5% to $30.10 on Monday, while copper fell 2.2% to $4.2260.
Euro zone
European shares closed mostly lower today. The eurozone's STOXX 600 fell 0.07%, Germany's DAX 40 fell 0.53% and France's CAC 40 fell 0.27%. Spain's IBEX 35 Index rose 0.12%, while London's FTSE 100 rose 0.02%.
Asia Pacific Markets
Asian markets closed mostly lower on Monday, with Japan's Nikkei 225 falling 0.92%, China's Shanghai Composite Index falling 0.06%, Hong Kong's Hang Seng Index gaining 0.66% and India's BSE Sensex dipping 1.08%.
Economics
<ul>
<li>The Chicago Fed National Activity Index rose to 0.15 in December, recording the strongest reading in seven months, and versus a revised -0.01 in the previous month.</li>
<li>U.S. building permits in rose by 0.7% to an annualized rate of 1.482 million in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43225242/wall-streets-most-accurate-analysts-give-their-take-on-3-utilities-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Utilities Stocks Delivering High-Dividend Yields</a></li>
</ul>

Eurozone

Commodities

AKRO

ELAB

VERU

S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher

Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) will report its fourth-quarter earnings on Tuesday. Wall Street expects an EPS loss of $2.44 on $16.17 billion in revenue when the plane manufacturer reports <a href="https://www.benzinga.com/quote/BA/earnings">before the market opens</a>.
The stock is down 14.2% over the past year, off 5.05% in the last six months, but has gained 2.44% year to date.
<h1 class="wp-block-heading">Boeing Faces A Tough Q4, But A Path Forward Emerges</h1>
Boeing already pre-announced a brutal quarter, with revenue of $15.2 billion — falling short of estimates — and a net loss of $5.46 per share.
The company expects to report a negative operating cash flow of $3.5 billion, bringing its total cash burn for 2024 to $13.7 billion. CEO Kelly Ortberg acknowledged the near-term challenges but emphasized a long-term recovery plan, including stabilizing production and improving operational efficiency.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/01/43179806/boeing-stock-falls-on-preliminary-q4-results-the-details">Boeing Stock Falls On Preliminary Q4 Results: The Details</a>
<h1 class="wp-block-heading">Boeing Stock Strongly Bullish Ahead Of Q4 Earnings</h1>
Despite the financial struggles, Boeing stock is showing strong bullish signals.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27110936/Screenshot-2025-01-27-at-7.07.53-PM.png" alt="" class="wp-image-751649" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27110936/Screenshot-2025-01-27-at-7.07.53-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27110936/Screenshot-2025-01-27-at-7.07.53-PM-300x235.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012725&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
The share price of $176.06 is above its eight-day ($172.27), 20-day ($173.58), 50-day ($163.59) and 200-day ($168.57) moving averages — all generating bullish signals.
The Moving Average Convergence Divergence (MACD) indicator stands at 2.29, suggesting continued bullish momentum. Additionally, the Relative Strength Index (RSI) sits at 59.08, indicating the stock is nearing overbought territory but still has room to run.
<h1 class="wp-block-heading">Boeing Analysts See 20% Upside</h1>
Ratings &amp; Consensus Estimates: The consensus analyst rating on BA stock stands at a Buy, with an average price target of $197.79. Citigroup, Barclays and Deutsche Bank recently rated Boeing stock. Their average price target of $210.67 suggests a 20.53% upside.
BA Price Action: Boeing stock was trading down 0.40% at $175.35 at the time of publication Monday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43188381/boeing-dips-in-pre-market-after-larger-than-expected-loss-estimate">Boeing Shares Drop Pre-Market As Labor Strikes Expected To Wipe $3.5B From Airplane Maker&#8217;s Q4 Cash Flow</a></li>
</ul>
Photo: Shutterstock

Technicals

Travel

Boeing's Q4 Looks Rough, But Wall Street Sees 20% Liftoff Ahead

WIIM

Pfizer shares are trading higher. The stock may be higher amid activist Starboard Value's decision to not pursue a proxy battle with the company.

i-80 GOLD CORP. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/IAU#TSX">IAU</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAUX#NYSE">IAUX</a>) ("i-80", or the "Company")&nbsp;is pleased to announce&nbsp;that, further to its news releases dated January 15, 2025 and January 16, 2025, it has filed a prospectus supplement (the "Prospectus Supplement") to its short form base shelf prospectus filed on June 21, 2024 (the "Shelf Prospectus") with the securities regulatory authorities in each of the provinces and territories of Canada other than Québec and with the U.S. Securities and Exchange Commission pursuant to the Company's U.S. registration statement on Form F-10 (Registration No. 333-279567, which includes the Shelf Prospectus and was declared effective by the United States Securities and Exchange Commission on June 25, 2024 to qualify the distribution of a minimum of 18,000,000 common shares of the Company (the "Offered Shares") at a price of C$0.80 per Offered Share (the "Offering Price") for minimum gross proceeds to the Company of C$14,400,000 (the "Minimum Offering") and a maximum of 36,250,000 Offered Shares at the Offering Price for aggregate gross proceeds of up to C$29,000,000 (the "Maximum Offering" and collectively with the Minimum Offering, the "Offering"). If subscriptions are not received for at least the gross proceeds of the Minimum Offering, the Offering will not be completed.
The size of the Offering has been increased from US$10 million to US$20 million (C$29 million). Subject to the receipt of all required regulatory approvals, including the approval of the Toronto Stock Exchange (the "TSX") and the NYSE American, the Offering is expected to close on or about January 31, 2025.

Offerings

IAUX

TSX:IAU

i-80 Gold Filed Prospectus Supplement For Maximum Offering Up To 36.25M Shares At C$0.80 Each, Aiming For Up To C$29M In Gross Proceeds; Offering Increased From US $10M To US $20M

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Cybin (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CYBN#AMEX">CYBN</a>) with a Buy and maintains $190 price target.

CYBN

HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target

RBC Capital analyst James McGarragle reiterates Air Canada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AC#TSX">AC</a>) with a Sector Perform and maintains C$23 price target.

TSX:AC

RBC Capital Reiterates Sector Perform on Air Canada, Maintains C$23 Price Target

Press Releases

ZTO Express to Hold Annual General Meeting on June 18, 2024

ZTO to Announce First Quarter Financial Results on May 15, 2024 U.S. Eastern Time

ZTO Reports First Quarter 2024 Unaudited Financial Results


Josh GottheimerHouse (D-NJ)	$1K - $15K	stock	Purchase	May 15, 2024	Apr 17, 2024	House
Josh GottheimerHouse (D-NJ)	$1K - $15K	stock	Purchase	May 15, 2024	Apr 16, 2024	House

Government Trades

ZTO Express (Cayman) Inc

top performing ZTO trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga